192 related articles for article (PubMed ID: 11042526)
1. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Tsujimura H; Takagi T; Tamaru J; Sakai C
Leuk Lymphoma; 2000 May; 37(5-6):633-4. PubMed ID: 11042526
[TBL] [Abstract][Full Text] [Related]
2. Natural killer T-cell lymphoma of the tongue.
Cho KJ; Cho SG; Lee DH
Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):55-7. PubMed ID: 15697163
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Wong KF; Chan JK; Cheung MM; So JC
Am J Clin Pathol; 2001 Feb; 115(2):266-70. PubMed ID: 11211616
[TBL] [Abstract][Full Text] [Related]
5. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
[No Abstract] [Full Text] [Related]
6. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
7. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
[TBL] [Abstract][Full Text] [Related]
8. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
9. Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Avilés A; Neri N; Fernández R; Calva A; Huerta-Guzmán J; Nambo MJ
Med Oncol; 2003; 20(1):13-7. PubMed ID: 12665679
[TBL] [Abstract][Full Text] [Related]
10. Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
Gutierrez A; Rodriguez J
Ann Oncol; 2008 Aug; 19(8):1512. PubMed ID: 18662957
[No Abstract] [Full Text] [Related]
11. IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Park BB; Kim WS; Lee J; Park KW; Kang JH; Lee SH; Park JO; Kim K; Jung CW; Park YS; Im YH; Kang WK; Ko YH; Lee MH; Park K
Leuk Lymphoma; 2005 Dec; 46(12):1743-8. PubMed ID: 16263576
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Kouzaki H; Kitanishi T; Kitano H; Suzuki M
Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
[TBL] [Abstract][Full Text] [Related]
13. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
[TBL] [Abstract][Full Text] [Related]
14. A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
Kamata M; Sugaya M; Miyagaki T; Sonoda K; Ichimura Y; Mitsui H; Sato S; Kamikubo Y; Kurokawa M
Int J Dermatol; 2014 Jan; 53(1):e24-6. PubMed ID: 23452101
[No Abstract] [Full Text] [Related]
15. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.
Sanda T; Lida S; Ito M; Tsuboi K; Miura K; Harada S; Komatsu H; Wakita A; Inagaki H; Ueda R
Int J Hematol; 2002 Feb; 75(2):195-200. PubMed ID: 11939269
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
[TBL] [Abstract][Full Text] [Related]
18. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
[TBL] [Abstract][Full Text] [Related]
19. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
[TBL] [Abstract][Full Text] [Related]
20. Successful allogeneic stem cell transplantation for Lennert lymphoma.
Uni M; Yoshimi A; Nakamura F; Takazawa Y; Fukayama M; Kurokawa M
Ann Hematol; 2013 Jun; 92(6):859-60. PubMed ID: 23224245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
